<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Taha benzitouna on Medium]]></title>
        <description><![CDATA[Stories by Taha benzitouna on Medium]]></description>
        <link>https://medium.com/@taha_benzi?source=rss-a58397209336------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*GO2eT8jflmIxyxOWgoHAKg.jpeg</url>
            <title>Stories by Taha benzitouna on Medium</title>
            <link>https://medium.com/@taha_benzi?source=rss-a58397209336------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Thu, 19 Nov 2026 22:23:19 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@taha_benzi/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[What is stopping scientists from making artificial blood that can be given to anyone in need?]]></title>
            <link>https://medium.com/@taha_benzi/what-is-stopping-scientists-from-making-artificial-blood-that-can-be-given-to-anyone-in-need-3f2d235a240e?source=rss-a58397209336------2</link>
            <guid isPermaLink="false">https://medium.com/p/3f2d235a240e</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[medical]]></category>
            <category><![CDATA[blood]]></category>
            <category><![CDATA[science]]></category>
            <category><![CDATA[blood-pressure]]></category>
            <dc:creator><![CDATA[Taha benzitouna]]></dc:creator>
            <pubDate>Mon, 01 Aug 2022 13:36:37 GMT</pubDate>
            <atom:updated>2022-08-01T13:40:56.144Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*jIHHtBRA-jZgSio4M9PiMQ.jpeg" /></figure><p>Severe bleeding naturally requires medical attention, especially in dangerous and isolated areas like battlefields. Therefore, after World War II, military scientists began to investigate the possibility of manufacturing blood, and soon civilian scientists followed, and thus began the quest of researchers to produce artificial blood.</p><p>This age-old quest may have begun to make progress recently, but identifying ethical ways to test synthetic blood products is a major challenge.</p><p>During the 17th century, doctors tried to treat their bleeding patients by transfusing milk and wine into their blood because they had no suitable alternative, and then they began using sheep blood after the operation failed, and it soon became apparent that these treatment options were actually fatal rather than beneficial.</p><p>Fortunately, we now know that human blood donated by a person with the same blood type as the recipient is the most appropriate option. After a person donates blood, it is filtered of impurities and its components are separated from each other and tested for possible blood-borne diseases, such as the human immunodeficiency virus (HIV).</p><p>However, this method is not perfect either. Health systems in some countries lack the infrastructure to collect, store and safely transport blood to patients when needed, and even in countries that do have these resources, there are “groups” with rare blood types for which it is difficult to find a matching group in the blood bank. These are usually ethnic minorities.</p><p>Scientists have not yet been able to successfully produce artificial blood, but they have made some progress. Instead of trying to copy whole blood and match its different components together, scientists are now looking at making the components of blood separately, including: red blood cells, which carry oxygen around the body; white blood cells, which fight infection; platelets, which form clots to heal wounds; and plasma, which carries many substances such as proteins.</p><p>In most countries, blood is also transfused in this way, as patients rarely receive whole blood.</p><p>Most of the time, one or more components of the blood are transfused to the patient according to his or her needs. Minor bleeding usually requires only red blood cells, while severe bleeding requires red blood cells as well as platelets and plasma.</p><p>The manufacture of blood products has been divided into two major areas of research. The first involves the production of fully synthetic materials that perform the same functions as blood components, while the second involves harnessing stem cells to generate cells and materials that are biologically identical to normal blood cells.</p><p>Each field has its pros and cons, but experts predict that some artificial blood products could be launched within the next 10 years if clinical trials prove successful.</p><p>“The blood donation rate dropped dramatically during the COVID-19 pandemic, forcing people to stay home,” says Koji Ito, a stem cell biologist at Kyoto University. So our efforts to try to produce artificial blood are very important, as they could ensure a stable blood supply in case we face future pandemics.”</p><h4>Synthesis of hemoglobin</h4><p>Blood cells contain a protein called hemoglobin, which is responsible for picking up oxygen in the lungs and transporting it to other organs in the body. Oxygen transport is one of the most important functions of blood, so it was important to study it in all artificial blood research.</p><p>The first experiment that prompted researchers to artificially produce blood products took place in the 1950s. Scientists used pure hemoglobin extracted from human or animal blood, and they expected that hemoglobin could carry oxygen even in the absence of the rest of the red blood cell components.</p><p>Over the next few decades, scientists chemically altered the hemoglobin proteins so that they would bind together and be difficult to break or separate, but trials of this technique were halted after a 2008 research review of nearly 16 studies including 3,700 participants showed that heart attacks were more common in patients treated with this method. Their mortality increased by 30%.</p><p>One possible reason for the increased risk of heart attack is that hemoglobin binds not only to oxygen, but also to nitric oxide, a substance that regulates the widening of blood vessels. Extracellular hemoglobin blocks the action of nitric oxide, which can reduce the blood supply to certain parts of the body, such as the heart.</p><p>“ Extra-cellular hemoglobin impairs the body’s ability to track blood motions, and the investigations were stopped for the obvious reasons.” Since then, scientists have focused on encapsulating hemoglobin to prevent it from binding to nitric oxide,” says Professor of Surgery and Military Medicine Michael Reed of the University of Queensland in Australia.</p><p>Matthew Armstrong, a chemical engineer who studied hemodynamics at the U.S. Military Academy. “Signs of the “ Foot “ will start to appear when it is removed from the body.”</p><p>“Nor are these experiments easily reproducible under the same conditions, because the blood changes during the day according to the person’s sporting activity and type of diet.”</p><p>Scientists are currently working on ways to extend the life of blood products outside the body, such as platelets, and some have suggested using the freeze-drying technique, but when the products are rehydrated, the flaws in this technology begin to show.</p><p>“The U.S. military has invested millions of dollars to produce an artificial blood substitute that can be used to rescue the wounded on the battlefield, but their investment has not paid off so far,” Armstrong says.</p><p>Armstrong says it is important to study the viscosity of synthetic blood products, the mechanics of their movement in fluids and their compatibility with natural blood products.</p><h4>Biomodified artificial blood</h4><p>Because producing artificial blood suitable for medical use is a difficult task, researchers have taken a different approach by manipulating stem cells into blood cells.</p><p>If scientists could biologically modify blood products (such as red blood cells and platelets) in this way, it would avoid the blood compatibility problems that researchers often fear when using synthetic blood products.</p><p>In this method, scientists extract a specific type of stem cell called a “hematopoietic stem cell” that can differentiate into any type of blood cell. The researchers then use signaling molecules to transform these stem cells into the desired blood product.</p><p>This method is well known and has been successfully applied by scientists for many years. In fact, Ito, of Kyoto University, says he successfully administered platelets produced from stem cells to a 52-year-old patient, describing the experience as a global precedent.</p><p>“Ultimately, this process stops because a single stem cell can only produce a limited number of red blood cells,” says Rebecca Griffiths of the Australian Red Cross Lifeblood research team, and scientists are starting to work on this problem.</p><p>In a paper published in 2017, Griffiths and her team demonstrated a process called “cellular immortalization,” in which the team injected stem cells with human papillomavirus when they were in an early stage of differentiation into red blood cells.”The virus stops the cell from growing further, which means it will not lose its ability to reproduce,” Griffiths says.</p><p>In theory, this method can provide a stable source of red blood cells that is not dependent on continuous stem cell donations, but it is not without its drawbacks.</p><p>Red blood cells have no nucleus, making them flexible enough to squeeze into tiny blood vessels without causing clots. When immortalized stem cells lose their nuclei as they turn into red blood cells, they get rid of the otherwise harmful HPV. However, some red blood cells produced in this way do not shed their nuclei properly, so researchers are trying to improve immortalization strategies to correct this defect.</p><h4>The clinical trial dilemma</h4><p>Reed says stem cell products are clearly distinguishable from synthetic products in clinical trials, but it’s not clear that scientists could get ethical consent from patients to dispense with the proven blood donation. Why would a patient choose artificial blood when some of the synthetic products tested to date have increased the risk of heart attack?</p><p>However, there are many situations in which donating blood may not be an option. For example, a soldier wounded on a remote battlefield may not care about the difference in effectiveness between artificial blood products and donated blood, because donor blood is not available in these circumstances: Is it better to have artificial blood products than nothing?</p><p>Trying to answer this question is scientifically difficult.”It is also hard to conduct a clinical trial in environments where natural transfusions are not possible,” Reed adds.</p><p>A retrospective study to compare the survival rates of people treated with artificial blood in emergency situations with those who do not receive it is possible, but it is subject to bias. People treated with an artificial blood product will initially survive their injury, but people who are severely injured and die instantly are not prime candidates for artificial blood, so this study probably overestimates the benefit of blood products. synthetic.</p><p>But if these problems are solved in the study’s experimental design, there are a number of promising treatments, Reid said. Regardless, these efforts are evidence of the great strides modern medicine has made since the days of milk and wine to save patients with hemorrhage.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3f2d235a240e" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[How does the medicine know its correct destination in the body?]]></title>
            <link>https://medium.com/@taha_benzi/how-does-the-drug-know-its-correct-destination-in-the-body-6e63c171dac5?source=rss-a58397209336------2</link>
            <guid isPermaLink="false">https://medium.com/p/6e63c171dac5</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[body]]></category>
            <category><![CDATA[pfizer]]></category>
            <category><![CDATA[medicine-practitioner]]></category>
            <category><![CDATA[medicine]]></category>
            <dc:creator><![CDATA[Taha benzitouna]]></dc:creator>
            <pubDate>Fri, 29 Jul 2022 16:04:44 GMT</pubDate>
            <atom:updated>2022-07-29T16:05:03.884Z</atom:updated>
            <content:encoded><![CDATA[<h3>How does the medicine know its correct destination in the body? Why are there different forms of medication?</h3><p>Have you ever thought about how aspirin, that little white pill, knows how to get to your head to stop the pain and relieve a headache?</p><p>The answer is simple: Drug molecules can’t move around the body on their own, and they don’t have the ability to control the fate that will lead them there, but researchers have been able to chemically modify drug molecules to make them strongly attached to the places we want to affect, and weakly attached to other places.</p><p>Pharmaceutical forms contain an active substance that works directly in the body, as well as inactive ingredients or molecules that improve the drug’s absorption, stability, flavor enhancers, and other properties necessary for a drug to work.</p><p>For example, the aspirin we take contains ingredients that prevent it from breaking down as it does its job and help it break down in the body.</p><p>The pharmaceutical scientist studies the mechanism of drug delivery, i.e. how to develop methods and design non-drug ingredients that help the drug reach its legitimate destination.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/750/1*UMabOpXxAjw4cCIzcWzZpw.jpeg" /></figure><p>To better understand the thought process behind the design of different drugs, we will highlight the journey of the drug from its intake to its destination and the achievement of the desired effect.</p><h4>How does the body absorb the drug?</h4><p>When you swallow a pill, it dissolves in your stomach and intestines before the drug molecules are absorbed into your bloodstream. Once in the bloodstream, they travel throughout the body to different organs and tissues, as the drug molecules affect the body by associating with different receptors in the cells that cause a specific response.</p><p>Although drugs are designed to target specific receptors to produce the desired effect, it is impossible to prevent them from continuing to circulate in the bloodstream and binding to non-targeted sites, which can lead to unwanted side effects.</p><p>Over time, drug molecules circulating in the blood break down, leave the body and are deposited in the urine. A classic example is the strong odor in the urine after eating asparagus, due to the rapid elimination of asparagic acid by the kidneys.</p><p>Similarly, multivitamins usually contain riboflavin or vitamin B2, which gives the urine a bright yellow color.</p><p>Because the ability of drug molecules to pass through the wall of the intestine varies according to the chemical properties of the drug, some drugs we take orally are never absorbed and are excreted in the stool.</p><p>The reason the patient takes the drug several times a day — such as patients with high blood pressure or allergies — is because of the variation in the absorption rates of the drug in the body. Therefore, the patient takes repeated doses throughout the day to compensate for the molecules that the body gets rid of and to maintain a high level of the active substance in the blood to achieve the desired therapeutic goal.</p><h4>Getting the medication to the right destination</h4><p>The most effective way to get the drug into the bloodstream is by injection directly into the vein, as opposed to pills or tablets, which ensures that it is distributed throughout the body and avoids damage to the stomach.</p><p>Many drugs administered intravenously are biological or biotechnological drugs, i.e. substances derived from living organisms. The most common example is cancer drugs, called monoclonal antibodies, which are proteins that bind to and kill cancer cells.</p><p>These drugs are injected directly into a vein. Because the stomach cannot distinguish between digesting a therapeutic protein and digesting a hamburger, in other cases, drugs that need a high concentration to be effective, such as antibiotics for serious infections, are given only by intravenous infusion.</p><p>While increasing the concentration of a drug can ensure that enough molecules bind to the right sites to have a therapeutic effect, it also increases the risk of off-target site side effects.</p><p>One way to achieve a high concentration of the drug is to apply it directly to the desired site, such as applying an ointment to the rash or using eye drops to treat allergies. This is unlikely to cause any side effects.</p><p>Also, the inhaler delivers the medication directly to the lungs and avoids affecting the rest of the body.</p><h4>Patient adherence to treatment</h4><p>One of the key aspects of drug design is to ensure that the patient takes the drug in the right amount at the right time.</p><p>Because many people have trouble remembering to take medications multiple times a day, researchers are trying to design drug combinations that require patients to take medications only once a day or less.</p><p>Pills, inhalers and nasal sprays are more convenient and comfortable for the patient than an IV infusion that requires them to go to the doctor and have a needle stuck in their arm.</p><p>The less inconvenient and expensive the medication is for the patient, the more likely they are to take it when they need it.</p><p>However, intravenous injections and infusions are sometimes the only effective way to administer the medication.</p><p>Finally, we can say that with all the science that goes into understanding the disease in order to develop an effective drug, it often differs for each patient.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6e63c171dac5" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Amazon is developing vaccines for theft, wellness and beyond.]]></title>
            <link>https://medium.com/@taha_benzi/amazon-is-developing-vaccines-for-theft-wellness-and-beyond-f2e498044a1d?source=rss-a58397209336------2</link>
            <guid isPermaLink="false">https://medium.com/p/f2e498044a1d</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[science]]></category>
            <category><![CDATA[amazon]]></category>
            <category><![CDATA[jeff-bezos]]></category>
            <category><![CDATA[vaccines]]></category>
            <dc:creator><![CDATA[Taha benzitouna]]></dc:creator>
            <pubDate>Wed, 27 Jul 2022 13:58:13 GMT</pubDate>
            <atom:updated>2022-07-27T14:01:22.538Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/384/1*zqATe--ZNRD68lbVgALqig.jpeg" /></figure><p>AMAZON develops cancer vaccines in partnership with the Fred Hutchinson Cancer Center in Seattle. According to a Business Insider report, these vaccines will treat breast cancer and skin cancer, also known as melanoma.</p><h4>Specific treatment for certain types of cancer</h4><p>According to an abstract published on Clinicaltrials.gov, the study began on June 9, 2022, and is scheduled to end on November 1, 2023. In the first phase of the first trial, 20 patients over the age of 18 are being sought to test an FDA-controlled pharmaceutical product. The study was confirmed by an Amazon representative.</p><p>“Amazon is bringing its scientific and machine expertise in partnership with the Fred Hatch Cancer Research Center to explore the potential for developing a treatment for certain types of cancer,” a spokesperson for Amazon said to Business Insider in an email . While it’s still early, Fred Hatch recently received FDA approval to begin a Phase I clinical trial, although the success of the treatment is not certain.”</p><p>He also said , “ We are prepared to collaborate with other organizations working in health care and life sciences with similar interests, as the trials will be long and take several weeks.”</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/635/1*0Iu0yQp_NsI-V1Qr1ARUqQ.jpeg" /></figure><p>The abstract describes the experiment as follows:</p><p>A phase 1 trial is investigating the safety of a peptide vaccine containing the novel antigen in the treatment of patients with IIIC-IV melanoma or HRT2-negative breast cancer that has spread to other parts of the body (metastatic) or is unresponsive to treatment (cancer). resistant to treatment).</p><p>The DPI-containing peptide vaccine is a product that combines several patient-specific induced antigens, and administration of the DPI-containing peptide vaccine with polarized Th1 helper T cells and poly ICLCs stimulates multiclonal, epitopic, and cytolytic T-cell immunity against patients’ tumors.</p><h4>Entering the health care sector</h4><p>Previously, Amazon entered the healthcare sector in June 2021, and the company launched Amazon Care, which provides Seattle-based employees with in-home medical assistance, such as virtual video chats with doctors, pharmacy home delivery of medications, and health consultations via a chatbot.</p><p>The newest treatment would be a vaccine produced by Amazon’s secret lab called Grand Challenge. The team working in Amazon’s oncology department reportedly made such progress that they were able to “graduate” from Grand Challenge and work under VP Hardware Robert Williams, people familiar with the matter told Business Insider on condition of anonymity. .</p><h4>What does this mean for Amazon?</h4><p>This means that the global company will add a new service: cancer treatment. And if the treatment is successful, you will reap huge financial benefits.</p><p>The question now is whether we want the multinational technology company to treat one of the most dangerous and deadly diseases. Is it not better to leave the treatment of cancer to doctors and health professionals? In time, the mechanism of action of these vaccines and this initiative will become clear.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f2e498044a1d" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[What is the lint that you find inside your navel?]]></title>
            <link>https://medium.com/@taha_benzi/what-is-the-lint-that-you-find-inside-your-navel-39505019df2?source=rss-a58397209336------2</link>
            <guid isPermaLink="false">https://medium.com/p/39505019df2</guid>
            <category><![CDATA[science]]></category>
            <category><![CDATA[education]]></category>
            <category><![CDATA[lint]]></category>
            <category><![CDATA[navel]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Taha benzitouna]]></dc:creator>
            <pubDate>Wed, 27 Jul 2022 13:18:03 GMT</pubDate>
            <atom:updated>2022-07-27T13:18:03.638Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/384/1*cZ8vyr14K97AYAwk7VasNg.jpeg" /></figure><p>There are two main things to know about the hair that forms inside the belly button, the first is that it is scientifically called “umbilical hair” even though it is sometimes referred to in scientific articles as “umbilical fuzz”, and the second is that belly button hair forms in middle age in men with thick hair. Those who have recently been weightlifting.</p><p>These results were obtained by a University of Sydney researcher named Karl Kruzelinsky, known to his fans through an Australian science radio program. In one episode, one of his listeners asked him where lint came from and how it formed, which gave Kruzelinsky the idea of distributing an online questionnaire, which led him to conclude that middle-aged hairy men suffer from this plague.</p><p>For his research, he received the Nobel Prize in 2002, while he was awarded a Medal of Honor for a research entitled “First Makes You Laugh, Then Makes You Think”.</p><p>In addition to the Internet-based questionnaire, (Kruzlinsky) and his colleagues collected samples from willing volunteers, and also asked some of them to shave their belly hair around the belly button.</p><p>Shaving the hair around the belly button has already been shown to prevent lint accumulation. While the world’s leading experts don’t know this, Dr. (Kruzlinsky) and his colleagues have come up with an explanation for why belly button lint forms, at least logically! The hair around your belly button acts like a one-way suction machine and steals the finest threads from your clothes and deposits them in your belly button.</p><h4>Old clothes for less dander</h4><p>Dr. Kruzelinsky isn’t the first to look at how belly button hair is formed around the world. In 2009, a researcher at the Vienna University of Technology, George Stenhauser, published a study that raised eyebrows in the journal Medical Hypotheses.</p><p>For some reason that no one knows about but him, (George) swabbed his belly button every night for three years. Although he maintained good personal hygiene by showering every morning, the belly button filled with hair every night.</p><p>George took 503 samples from his belly button, all of which did not weigh a single gram.</p><p>On average, a single piece has a mass of 1.82 milligrams, but seven pieces weighed more than 7.2 milligrams, and the largest weighed 9.17 milligrams.</p><p>“It is clear that this lint is from cotton fibers, as it is the same color as the sweater he was wearing,” Kruzelinsky wrote. He collected less lint when he wore old clothes, probably because they had been previously cleaned of stray cotton fibers, such as when he wore clothes buttoned from below.</p><p>Stonehauser came to the same conclusion as Kruzelinsky: the hair around the belly button is the one responsible for collecting lint, and this proved that the hair itself scraped the tiny fibers from the sweater, then directed them to the belly button where they accumulated, “the hair behaves like a picker dog.” According to him, “after I shaved off the hair around my belly button, the whole gathering of the belly button was cut off.”</p><p>But (George) took his research a step further, as he analyzed the chemical composition of the belly button hair sample he collected after wearing a 100% cotton sweater. Other materials were also folded into the belly button.</p><p>Based on the results of the chemical analysis, (George) suspects that these remnants contain house dust, skin flakes, fats, proteins and sweat, apparently indistinguishable from belly button hair.</p><p>On this basis, it has been proven that these things that are collected by the navel make it clean and healthier. When it is removed, it carries away everything that is in its path.</p><p>While very few researchers devote their time and energy to finding the origin of belly button hair, perhaps only George and Kruzlinski have conducted serious research on the subject. Work is underway at the University of North Carolina to understand what else lives in our belly button.</p><p>Rob Dunn, a researcher in NCSU’s biology department, created a civic science project called The Navel Variation.</p><p>In 2011, Rob Dunn and his colleagues collected samples from more than 500 volunteers at the online science conference in Raleigh, North Carolina, and at Yodd Darwin at the Raleigh Museum of Natural Science.</p><p>But the researchers were never interested in dander; all they wanted was to understand the belly button microbiome.</p><p>“The duck’s belly button is one of the closest habitats to us and yet it is still relatively undiscovered.”</p><p>That’s what they wrote, so these researchers are determined to discover what lives in our secret.</p><p>From this initial study (there was a second round of sampling), Dan and his team discovered a huge amount of microbes living in the belly button and a diverse form of microscopic life.</p><h4>Coexistence (adaptation) in the navel</h4><p>The researchers found in at least 60 specimens 2,368 species and suspect that the number is much higher. To put this number in context, it exceeds the biodiversity of North American birds and ants.</p><p>But most of these species were rare, with 2,128 species occurring in fewer than six individuals and most of them being observable in a single individual.</p><p>The researchers also found some very old species that live only in harsh environments.</p><p>Interestingly, two of the three species found in a single person had not showered in several years.</p><p>Dan asks why there is so much biodiversity in the belly button. (Dan) and his colleagues suspect that it is due to a certain class of organisms that have adapted to live on human skin or have adapted to live in the belly button itself, and perhaps some of them are a passing visitor that was picked up on a beach.</p><p>Since it is impossible for scientists to predict how many types of bacteria live in the human belly button, all researchers can do is predict which are more common or rarer.</p><p>Even if your belly button doesn’t consistently form that hairball, it’s still a wonderful place, full of excitement and teeming with life.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=39505019df2" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Antarctica records lowest sea ice in nearly 40 years !]]></title>
            <link>https://medium.com/@taha_benzi/antarctica-records-lowest-sea-ice-in-nearly-40-years-a55a8a509e98?source=rss-a58397209336------2</link>
            <guid isPermaLink="false">https://medium.com/p/a55a8a509e98</guid>
            <category><![CDATA[nature]]></category>
            <category><![CDATA[oceans]]></category>
            <category><![CDATA[antarctica]]></category>
            <category><![CDATA[global-warming]]></category>
            <dc:creator><![CDATA[Taha benzitouna]]></dc:creator>
            <pubDate>Wed, 06 Apr 2022 00:41:08 GMT</pubDate>
            <atom:updated>2022-08-03T17:52:20.652Z</atom:updated>
            <content:encoded><![CDATA[<h3>Antarctica records lowest sea ice in nearly 40 years !</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/554/1*Gkb7xmMTx5Sr--YIkNP8Vg.png" /></figure><p>This year’ s February satellite images showed a decline in sea ice coverage, but Antarctic sea ice quantity varies widely each year, and the changing weather patterns may not be the cause of this, the National Snow and Ice Data Center announced on the eighth From this March, the extent of sea ice (a measure of sea ice in the ocean) around Antarctica shrunk to less than two million square kilometers on February 25 for the first time since scientists began recording it in 1979.</p><p>Global warming may be a contributing factor, but Antarctica’s sea ice is highly variable, according to Nature. The shrinkage may be natural, in part because strong winds push some sea ice northward into warmer waters. “I suspect that natural variability may have caused most, if not all, of the event,” Walt Meyer, an advanced research scientist from the National Snow and Ice Data Center, told Nature.</p><p>Seawater is ice that floats on the surface of the ocean . According to the National Snow and Ice Data Center, sea ice forms on the surface of the ocean, and unlike icebergs and other ice that breaks away from land, sea ice is usually covered in snow. The new data capture the limits on minimum annual sea ice extent in late summer, allowing the measure of ocean sea ice extent to be at its lowest in the year following the southern hemisphere’s summer melt.</p><p>Sea ice in Antarctica varies greatly from year to year, and the National Snow and Ice Data Center has not found a statistically significant path one way or another via satellite data, and this year the lowest minimum extent of sea ice extent was recorded so far, but the minimum The highest sea ice extent was recorded in 2015.</p><p>According to the National Snow and Ice Data Center, Antarctica is surrounded by water, wind currents, and the ocean insulate it from weather patterns found elsewhere on Earth. In the Arctic, it is more important to decipher global climate trends, and to highlight the impact of climate change on rising temperatures.</p><p>Arctic satellite imagery shows a clear linear decline in sea ice over the past 44 years. The Antarctic sea area is 1.82 million square kilometers. That’s more than Alaska’s land area (1.5 million square kilometers), according to Alaska’s official website.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a55a8a509e98" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>